The healthcare industry is undergoing a profound transformation, and one startup, Doccla, is at the forefront of this change. With a successful track record in the U.K. and Ireland, Doccla has recently raised £35 million ($46 million) to further expand its innovative “hospital at home” model across Europe. This fresh influx of funding is pivotal, not just for the company’s growth but also for addressing the pressing issue of hospital bed shortages, especially highlighted during health crises like Covid-19.
The ‘Virtual Bed’ Concept: A New Approach to Patient Care
Doccla’s core offering is centered around its “virtual bed” technology, which empowers healthcare providers to monitor patients remotely. Whether patients are discharged early or, in some cases, do not need to enter a hospital at all, Doccla facilitates effective care in the comfort of their own homes. The technology includes a set of monitoring devices and a mobile application, which captures and transmits vital health data directly to doctors. This innovative approach not only alleviates the pressure on physical hospitals but also enhances patient experience and outcomes.
Funding and Future Expansion
Led by Lakestar, the Series B funding round has attracted notable participation from investors like Elaia and existing stakeholders. Compared to its previous funding of $17 million in a Series A round, this significant investment signals a robust faith in Doccla’s model. The funds will be utilized for local team hiring as the company strategically launches in new European markets like Austria and France. The startup’s co-founder, Martin Ratz, emphasizes a revenue-first approach, aiming to ensure a solid customer base before entering new territories.
Streamlined Integration with Healthcare Providers
Doccla’s method of entering markets is refreshingly practical: they ensure the establishment of a customer partnership before launching operations in a new location. For instance, in Germany, the startup identified a local healthcare provider to align with, thereby setting up a foothold in that region. As they expand, they are acutely aware of the varying healthcare landscapes and reimbursement structures across different countries, which supports their customized approach.
Innovation in Drug Trials
Beyond patient care, Doccla is making strides in the pharmaceutical arena. Their technology is currently being utilized in clinical trials, reducing the necessity for patients to physically attend trials at clinical settings. The company’s model of conducting remote monitoring allows for more efficient and cost-effective drug research. Ratz reported, “We can help do things faster, better, cheaper than traditional CROs,” showcasing the practical benefits of their approach.
Focus on Accessibility and User Experience
In a landscape increasingly awash with digital health solutions, Doccla remains committed to making healthcare accessible. The application is designed with simplicity in mind—featuring large text, intuitive navigation, and in-app functionalities that allow patients to communicate directly with clinicians via messaging and video calls. This feature not only enhances patient satisfaction but also fosters a sense of personal connection that traditional settings sometimes lack.
Conclusion: Paving the Way for Future Healthcare
Doccla represents a significant advancement in the healthcare industry, providing a compelling response to bed shortages while enhancing patient engagement through its virtual solutions. As the startup continues to grow and refine its services across European territories, it sets a benchmark for other players in the virtual health marketplace. With technology like Doccla’s leading the charge, the future of healthcare looks brighter, more efficient, and easily accessible.
At **[fxis.ai](https://fxis.ai)**, we believe that such advancements are crucial for the future of AI, as they enable more comprehensive and effective solutions. Our team is continually exploring new methodologies to push the envelope in artificial intelligence, ensuring that our clients benefit from the latest technological innovations.
For more insights, updates, or to collaborate on AI development projects, stay connected with **[fxis.ai](https://fxis.ai)**.